Skip to main content
SpringerLink
Log in

Sepsis: needs for defining severity

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421

    Article  CAS  PubMed  Google Scholar 

  2. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583–1593

    Article  CAS  PubMed  Google Scholar 

  3. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:1381–1391

    Article  CAS  PubMed  Google Scholar 

  4. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683–1693

    Article  CAS  PubMed  Google Scholar 

  5. The ARISE Investigators and the ANZICS Clinical Trials Group (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496–1506

    Article  Google Scholar 

Download references

Conflicts of interest

LG reports grant support from the Italian Medicines Agency (AIFA, Agenzia Italiana del Farmaco) while conducting the ALBIOS study as well as speaker's fees from Grifols, Kedrion and Baxter and Advisory Board honoraria from Grifols outside the submitted work. VMR reports consultancies for MAQUET and a grant for the FARON_FPCLI001 clinical study with FP-1201 in acute lung injuries outside the submitted work. AP reports grant support from the Italian Medicines Agency (AIFA, Agenzia Italiana del Farmaco) while conducting the ALBIOS study, grant support from Chiesi Farmaceutici, consultancies for Maquet and Novalung, and fees for mechanical ventilation courses from Draeger outside the submitted work. The authors state that the subject discussed in the submitted manuscript was not dependent on financial support.

Author information

Authors and Affiliations

  1. Dipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy

    Luciano Gattinoni

  2. Department of Anesthesia and Intensive Care Medicine, S.Giovanni Battista Molinette Hospital, University of Turin, Turin, Italy

    V. Marco Ranieri

  3. Dipartimento di Scienze della Salute, Università degli Studi di Milano Bicocca, Milan, Italy

    Antonio Pesenti

  4. Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Via Francesco Sforza 35, 20122, Milan, Italy

    Luciano Gattinoni

Authors
  1. Luciano Gattinoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Marco Ranieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Pesenti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luciano Gattinoni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gattinoni, L., Ranieri, V.M. & Pesenti, A. Sepsis: needs for defining severity. Intensive Care Med 41, 551–552 (2015). https://doi.org/10.1007/s00134-014-3598-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-014-3598-8

Keywords

Search

Navigation